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Abstract. It is clear that alcohol consumption is a major risk 
factor in the pathogenesis of head and neck squamous cell 
carcinoma (HNSCC); however, the molecular mechanism 
underlying the pathogenesis of alcohol-associated HNSCC 
remains poorly understood. The aim of the present study 
was to identify and characterize P-element-induced wimpy 
testis (PIWI)-interacting RNAs (piRNAs) and PIWI proteins 
dysregulated in alcohol-associated HNSCC to elucidate 
their function in the development of this cancer. Using next 
generation RNA-sequencing (RNA-seq) data obtained from 
40 HNSCC patients, the piRNA and PIWI protein expression of 
HNSCC samples was compared between alcohol drinkers and 
non-drinkers. A separate piRNA expression RNA-seq analysis 
of 18 non-smoker HNSCC patients was also conducted. To 
verify piRNA expression, reverse transcription-quantitative 
polymerase chain reaction (RT-qPCR) was performed on the 
most differentially expressed alcohol-associated piRNAs in 
ethanol and acetaldehyde-treated normal oral keratinocytes. 
The correlation between piRNA expression and patient 
survival was analyzed using Kaplan-Meier estimators and 
multivariate Cox proportional hazard models. A comparison 
between alcohol drinking and non-drinking HNSCC patients 
demonstrated that a panel of 3,223 piRNA transcripts were 
consistently detected and differentially expressed. RNA-seq 
analysis and in vitro RT-qPCR verifica tion revealed that 
4 of these piRNAs, piR-35373, piR-266308, piR-58510 and 
piR‑38034, were significantly dysregulated between drinking 
and non-drinking cohorts. Of these four piRNAs, low expres-
sion of piR‑58510 and piR‑35373 significantly correlated with 
improved patient survival. Furthermore, human PIWI-like 
protein 4 was consistently upregulated in ethanol and 
acetaldehyde-treated normal oral keratinocytes. These results 
demonstrate that alcohol consumption may cause dysregula-
tion of piRNA expression in HNSCC and in vitro verifications 
identified 4 piRNAs that may be involved in the pathogenesis 
of alcohol-associated HNSCC.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is the sixth 
most common type of cancer worldwide and despite overall 
advances in cancer treatment, mortality rates of HNSCC have 
not improved significantly in the past three decades (1,2). Early 
diagnosis of HNSCC results in a 5-year survival rate of 75%; 
however, the majority of HNSCC patients present with meta-
static disease at the time of diagnosis and thus exhibit a 5-year 
survival rate of 35% (3). Therefore, it is critical to understand 
the molecular basis of HNSCC pathogenesis and identify the 
early genetic and epigenetic changes to enable early detection 
and diagnosis of HNSCC.
Alcohol consumption, in addition to other factors, 
including tobacco use and human papilloma virus infection, is 
a well-established major risk factor for HNSCC (4). Over 75% 
of HNSCC cases are caused by alcohol consumption and/or 
tobacco use (5). Although both habits are commonly linked, 
alcohol consumption has also been identified as an indepen-
dent risk factor for HNSCC (6,7). However, the mechanism 
by which alcohol leads to cellular transformation and the 
molecular basis of this risk remains unclear.
Recently, the field of epigenetic research has gained 
increasing attention as it has been revealed that alterations in the 
epigenetic landscape play a role in HNSCC pathogenesis (8,9). 
More specifically, non‑coding RNAs (ncRNAs) are considered 
critical in the development of many diseases, including 
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cancer (10). In 2006, a novel group of ncRNAs, termed 
P-element-induced wimpy testis (PIWI)-interacting RNAs 
(piRNAs), was identified in mammalian germ line cells (11). 
piRNAs are 24-30 nucleotides in length and associate with 
PIWI-class Argonaute proteins (12,13). Their main biological 
functions include PIWI-dependent transposon silencing, 
heterochromatin modification, and germ cell maintenance (14). 
As cancer cells and germ cells share a number of biological 
features, such as rapid proliferation and an undifferentiated 
state, piRNAs are currently being investigated in the context 
of cancer. Several studies have demonstrated that piRNAs 
exhibit both oncogenic and tumor suppressive functions in a 
variety of cancer types, including gastric, breast, and colon 
cancer (14-17).
The newly identified piRNAs are involved in a myriad of 
gene regulation functions and therefore present a promising 
field of study. Currently, their precise function in carcino-
genesis is unclear; however, this novel class of ncRNAs may 
present potential therapeutic targets or prognostic biomarker 
for early detection. To increase current knowledge of piRNAs, 
the present study aimed to determine the effects of alcohol 
consumption on piRNAs expression in HNSCC. Using 
RNA-sequencing (RNA-seq) analysis of HNSCC tissue 
samples obtained from alcohol drinkers and non-drinkers, 
we aimed to identify a panel of differentially expressed 
piRNAs between these two cohorts. Verification of these 
alcohol-associated piRNAs in ethanol treated normal oral 
keratinocyte cells allows us to determine the piRNAs poten-
tially involved in the early events of HNSCC pathogenesis.
Materials and methods
piRNA expression analysis. External RNA-seq datasets and 
corresponding clinical information of 40 HNSCC patients 
were obtained from The Cancer Genome Atlas (TCGA) 
(https://tcga-data.nci.nih.gov), which contained RNASeq or 
RNASeqv2 HNSCC data. Each of the datasets obtained was 
aligned to a human reference genome, (hg19) using Tophat 
(https://ccb.jhu.edu/software/tophat/index.shtml) (18) and 
piRNA transcript assembly was performed using Cufflinks 
(http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/) (18). 
Differential expression analysis was performed using Cuffdiff, 
the Cufflinks transcript quantification engine (18). piRNAs 
with extremely low expression [Fragments Per Kilobase of 
transcript per Million mapped reads (FPKM) of <1 in >50% 
of the samples] were excluded from the analysis. piRNAs with 
expression that differed by a fold change >1 in magnitude 
(P<0.05) between drinkers and non‑drinkers were identified 
by Cuffdiff to be differentially expressed. To generate a more 
selective panel of piRNAs for further analysis, more stringent 
filtering of the piRNAs was performed based on differen-
tial expression levels that were >two-fold (P<0.05). TCGA 
obtained written informed consent from all patients prior to 
publishing datasets.
piRNA survival analysis. All clinical data used in the analysis 
was obtained from TCGA. For survival analysis, piRNA 
expression was modeled as a binary variable, with the ‘low 
expression’ group corresponding to half of HNSCC patients 
with expression below the median, and ‘high expression’ 
corresponding to the remaining half of patients with expression 
above the median. For multivariate Cox analysis, covariates 
included patient age, clinical stage, pathologic stage, sex and 
tumor grade. The statsoft STATISTICA software version 12 
was used for all survival analyses.
Cell lines and cell culture. Two normal oral keratinocyte cell 
lines, OKF4 and OKF6, were provided by the Rheinwald 
Lab at Harvard Medical School (Boston, MA, USA). The 
oral keratinocytes were cultured in keratinocyte serum-free 
medium (SFM; 1X) with L-glutamine, supplemented with 
0.2 ng/ml human recombinant epidermal growth factor (EGF) 
1-53 (recombinant 1-53 of EGF), 25 µg/ml bovine pituitary 
extract (BPE), 0.3 mM CaCl2 and penicillin streptomycin 
(Thermo Fisher Scientific, Inc., Waltham, MA, USA). At 
30% confluence, the cells were cultured at 37˚C and at 5% CO2 
for 3 weeks with equal parts keratinocyte-SFM medium and 
DFK. DFK medium was made with equal parts Dulbecco's 
modified Eagle's medium and F‑12 (Corning Inc., Corning, 
New York, NY, USA), and supplemented with 0.2 ng/ml EGF 
1-53, 25 µg/ml BPE, 2 mM L-glutamine, and 10 ml penicillin 
streptomycin (10,000 units/ml penicillin, 10,000 ug/ml strep-
tomycin).
Ethanol and acetaldehyde treatment. Oral keratinocyte cell 
lines OKF4 and OKF6 were plated on 60x15 mm non-pyrogenic, 
non-cytotoxic plates (SARSTEDT, North Rhine-Westphalia, 
Nümbrecht, Germany) at 10% confluence. After reaching 
>30% confluence, they were then treated with increasing doses 
of ethanol and acetaldehyde to simulate the effects of alcohol 
consumption on human oral epithelial cells prior to carcinogen-
esis. Clinically relevant ethanol concentrations of 0.1, 0.3, and 
1% (v/v) were selected to replicate the alcohol levels of social, 
moderate and heavy drinkers, respectively. Long term alcohol 
consumption was simulated via daily treatment with ethanol 
diluted in oral keratinocyte‑SFM (Thermo Fisher Scientific, 
Inc.) for 28 days. Ethanol and growth medium were replaced 
daily and plates were sealed with paraffin film to prevent ethanol 
evaporation.
Oral keratinocyte cell lines OKF4 an OKF6 were also 
treated with acetaldehyde (Sigma-Aldrich; Merck KGaA, 
Darmstadt, Germany), the first metabolite of ethanol and 
a potential carcinogen. Physiologically relevant doses 
of acetaldehyde were used, as determined by saliva 
concentrations in alcohol consumers (19). Therefore, cells 
were treated with 75, 150 and 300 µm acetaldehyde diluted in 
growth medium for 48 h. Acetaldehyde and growth media were 
replaced every 4 h. Due to the volatility and short half-life of 
acetaldehyde, long-term treatment was not possible and thus 
had to be administered every 4 h. Cell lines were passaged to 
30‑80% confluence prior to harvesting RNA for subsequent 
experiments.
Verification of differential expression by reverse transcrip‑
tion‑quantitative polymerase chain reaction (RT‑qPCR). 
Approximately 45 µl of total RNA was extracted from 
cultured cells using the RNeasy Mini kit (Qiagen, Hilden, 
Germany). cDNA was then synthesized using reverse 
transcriptase (Invitrogen; Thermo Fisher Scientific, Inc.), 
according to the manufacturer's instructions. Quantitative 
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PCR was performed using SYBR-Green Reagent (Roche 
Diagnostics, Basel, Switzerland), Ultrapure Water (RX 
Biosciences; Gaithersburg, MD, USA), as well as the neces-
sary cDNA and primers. The reaction was run using the 
Applied Biosystems 7300 Real-Time PCR System (Applied 
Biosystems; Thermo Fisher Scientific, Inc.) which ran a 2 h 
PCR consisting of a 20 sec holding stage where the reaction 
is held at 95˚C, followed by a cycling stage consisting of 3 sec 
at 95˚C, then 30 sec at 60˚C. This cycling stage was repeated 
40 times before concluding with a melt curve stage, where 
the reaction is held at 95˚C for 15 sec, 60˚C for 1 min, then 
95˚C again for another 15 sec. Experiments were performed 
in triplicate and relative expression of piRNAs was calculated 
and normalized using the 2-ΔΔCt method (20) relative to U6 
control. Primers were designed and synthesized by Eurofins 
Genomics (Huntsville, AL, USA). The primer sequences 
were as follows:
piR-258904, 5'-TGA GAA CAT TGG ATT TTT CA-3'; 
piR-35373,  5'-TCC ACA CAC CAA GCC TTG GA-3'; 
piR-266308, 5'-ACG GCC CTG GCG GAG CGC AA-3'; 
piR-34946,  5'-TCA TGA GGT CAG GAG TTC AA-3'; 
piR-58510, 5'-GCC TGG CCA ACA TGG CAA AA-3'; 
piR-43219, 5'-CAC CTT GGG AGG CCA A-3'; piR-38034, 5'-TCG 
CTT GAA CCT GGA A-3' and piR-70732, 5'-TGA TGA TGG TGG 
TGG TGG TGT CGG TGA-3'U6 Human forward control 
primer, 5-CGC AAG GAT GAC ACG CAA ATT C-3'.
The forward and universal reverse primer were both 
provided in the QuantiMir RT kit Small RNA Quantitation 
System (System Biosciences, Palo Alto, CA, USA) and were 
used as per manufacturer's instruction, the sequence to the 
reverse primer is commercialized and thus not available.
Statistical analysis. The two-tailed student's t test was used 
to test for statistical significance between the two cohorts in 
every in vitro analysis as well as survival tests. The signifi-
cance of the tests in the differential and survival analyses 
was automatically calculated by the software provided, which 
were Statsoft by STATISTICA and Cuffdiff maintained by the 
Trapnell Lab. P<0.05 was considered to indicate a statistically 
significant difference.
Results
Identification of differentially expressed piRNAs associated 
with alcohol consumption. RNA-seq data was analyzed to 
determine the difference in piRNA expression between alcohol 
drinker and non-drinker HNSCC patients using data obtained 
Table I. Demographics and clinicopathological characteristics of 40 head and neck squamous cell carcinoma patients.
 Non-drinkers (n=20 Drinkers (n=20)
 --------------------------------------------------------- ---------------------------------------------------------
 Total patients Smokers Non-smokers Smokers Non-smokers
Parameter n (%) n (%) n (%) n (%) n (%)
Sex     
  Male 28 (70) 6 (55) 5 (56) 10 (91) 7 (78)
  Female 12 (30) 5 (45) 4 (44) 1 (9) 2 (22)
Alcoholic drinks per day, n=0     
 20 (50) N/A N/A 0 (0) 0 (0)
  1-2 5 (13) N/A N/A 0 (0) 5 (56)
  >2 15 (37) N/A N/A 11 (100) 4 (44)
Vital status     
  Deceased 32 (80) 7 (64) 8 (89) 9 (82) 8 (89)
  Alive 8 (20) 4 (36) 1 (11) 2 (18) 1 (11)
Tumor site     
  Oral 24 (60) 8 (73) 6 (67) 6 (55) 4 (44)
  Pharyneal 10 (25) 1 (9) 3 (33) 1 (9) 5 (56)
  Laryngeal 6 (15) 2 (18) 0 (0) 4 (36) 0 (0)
Tumor stagea     
  I/II 9 (23) 2 (20) 1 (11) 3 (27) 3 (33)
  III/IV 30 (77) 8 (80) 8 (89) 8 (73) 6 (67)
Tumor grade     
  GX 1 (2) 0 (0) 0 (0) 0 (0) 1 (11)
  G1-G2 30 (75) 10 (91) 7 (78) 8 (73) 5 (56)
  G3-G4 9 (23) 1 (9) 2 (22) 3 (27) 3 (33)
aData for 1 patient of the non-drinker/non-smoker group was not available. All patient data was obtained from The Cancer Genome Atlas. N/A, 
not applicable. 
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from TCGA. The patient cohort included 20 alcohol drinkers 
and 20 non-drinkers with equal numbers of smoker and 
non-smokers in each group (Table I). The primary sequence 
data files of each patient in the cohort were downloaded 
from the controlled access data tier of the Cancer Genomics 
Hub (https://cghub.ucsc.edu/). The data files were then 
mapped to a piRNA reference using Tophat and transcripts 
were assembled using Cufflinks. Based on the normalized 
FPKM output, the differential expression of 3,223 piRNA 
transcripts was compared between the alcohol drinkers and 
non-drinkers (Fig. 1). From the expressed transcripts, piRNAs 
that exhibited a fold change >2 (P<0.05) between alcohol 
drinkers and non-drinkers were considered to be differentially 
expressed. Using these parameters, upregulation of piR-58510, 
-43219, -38034, -34946 and downregulation of piR-70732 was 
identified in alcohol drinkers (Table II). In order to determine 
the piRNAs independently affected by alcohol consumption 
alone, the same analysis was performed in the non-smoking 
patient cohort. The results revealed an upregulation of 
piR-258904, -35373, -266308 and -34946 in the alcohol 
drinking, non-smoking cohort.
Expression of piR‑58510 and piR‑35373 correlates with better 
patient survival. Using the available clinical data for the entire 
Figure 1. Analysis of RNA-sequencing data of HNSCC samples. (A) Heatmap representing the piRNA FPKMs of the entire patient cohort (n=40). Patients 
were divided into drinking and non-drinking cohorts and further subdivided by tobacco usage. Only piRNAs that were expressed in >20 patients are shown. 
(B) Kaplan Meier curves indicate that low expression of piR-58510 and piR-35373 is associated with longer survival times. Log rank tests were performed 
to determine the P-values shown. (C) Cox proportional hazard ratios further demonstrate the correlation between piRNA-58510 and piR-35373 expression 
and overall prognosis. The hazard ratios presented for both univariate and multivariate tests are based on the low expression of each piRNA. Vertical lines 
represent censored patients. HNSCC, head and neck squamous cell carcinoma; PIWI, P-element-induced wimpy testis; piRNA, PIWI-interacting RNA; 
FPKM, Fragments per Kilobase of transcript per Million mapped reads; HR, hazard ratio; CI, confidence interval.
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patient cohort, the association between each differentially 
expressed piRNA and patient survival time was analyzed. The 
patient cohort was divided into high and low piRNA expres-
sion groups for univariate and multivariate Cox proportional 
hazard test analysis (adjusted for age and sex). Testing the 
8 piRNAs found to be dysregulated in the RNA-seq analysis 
(-58510, -43219, -38034, -34946, -258904, -35373, -266308), 
revealed that only piR-58510 and piR-35373 exhibited a 
significant correlation to survival (P<0.05) (Fig. 1B and C). 
These results indicated that low expression of piR-58510 and 
piR-35373 correlates with longer patient survival times.
In vitro ethanol exposure leads to dysregulation of identi‑
fied piRNAs in normal oral keratinocytes. To validate that 
the clinically relevant piRNAs identified were associated 
with alcohol consumption, in vitro ethanol treatment using 
early passage oral epithelial culture cells OKF4 and OKF6 
was performed. Normal oral epithelial cells were selected 
in order to investigate whether alcohol causes malignant 
transformation via dysregulation of the identified piRNAs. 
To mimic alcohol consumption, cell cultures were exposed to 
0.1, 0.3, 1% ethanol daily for 4 weeks to simulate the alcohol 
levels of social, moderate and heavy drinkers, respectively. 
A preliminary MTS assay was performed to demonstrate 
that the selected doses did not cause significant cell toxicity 
(data not shown). Following treatment, RT-qPCR assays were 
performed to analyze the expression of each of the piRNAs 
identified from analysis of the clinical data. The data demon-
strated that ethanol caused an upregulation of piR-35373, 
-266308, -58510, and -38034, which was consistent with the 
results obtained in the analysis of the RNA-seq data (Fig. 2A). 
Notably, the highest upregulation of these piRNAs occurred 
following treatment with 0.1% ethanol.
In vitro acetaldehyde exposure leads to dysregulation of 
identified piRNAs in normal oral keratinocytes. Although 
alcohol consumption is a major risk factor for HNSCC, ethanol 
alone is not considered a carcinogen. However, acetaldehyde, 
the first metabolite of ethanol is a known carcinogen. To further 
validate that the candidate piRNAs (piR-35373, -266308, 
-58510 and -38034) are involved in alcohol-associated HNSCC, 
cells were treated with physiologically relevant doses of 
acetaldehyde for 48 h. A significant upregulation in piR‑35373, 
piR‑266308 and piR‑38034 was identified in both OKF4 and 
OKF6 cell lines (P<0.05), with dose dependence stopping 
the effects at 300 mM, where high cell death is suspected to 
have affected expression of the piRNAs. The upregulation of 
those three pi-RNAs was similar to that observed with in vitro 
ethanol treatment. However, no significant differences in the 
expression levels of piR‑58510 were identified in OKF4 or 
OKF6 cells following treatment with acetaldehyde (Fig. 2B).
Ethanol and acetaldehyde exposure leads to dysregulation of 
PIWI‑like protein 4 (PIWIL4). Although the role of piRNAs 
in cancer development remains unclear, their binding proteins 
are well-characterized and the 4 PIWI proteins expressed in 
humans have been demonstrated to exhibit functional involve-
ment in a variety of cancer types (14). Of the 4 PIWI proteins 
identified (PIWIL1, PIWIL2, PIWIL3, PIWIL4), only the 
relative expression level of PIWIL4 was dysregulated in cells 
exposed to both ethanol and acetaldehyde treatments (Fig. 3).
Discussion
Alcohol consumption has been identified as a risk factor for the 
pathogenesis of HNSCC. Despite recent advances in HNSCC 
treatment, few studies has been published regarding the 
epigenetic biomarkers of alcohol-associated HNSCC (8), and 
survival rates for the disease have exhibited little improvement 
in the past three decades (21). The importance of epigenetics 
in alcohol-associated HNSCC remains unclear and elucidating 
its function may lead to the development of novel diagnostic 
and therapeutic targeting strategies (22).
To the best of our knowledge, the present study is the first to 
investigate the expression of piRNAs in HNSCCs. In addition, 
to date no studies have analyzed the effects of environmental 
factors or substance use on the expression of piRNAs and the 
present study is the first to demonstrate a dysregulation of 
Table II. Differentially expressed piRNAs and their corresponding fold changes in expression.
piRNA Fold change P-value Sequence (5'-3')
Non-smokersa   
  piR-258904 3.26275255 0.031 TGAGAACATTGGATTTTTCACCCTAG
  piR-35373 2.76213293 0.031 TCCACACACCAAGCCTTGGATTGGTCTGG
  piR-266308 2.57372618 0.019 ACGGCCCTGGCGGAGCGC
  piR-34946 2.29238305 0.027 TCATGAGGTCAGGAGTTCAAGACCAGCC
All patientsb   
  piR-58510 5.242446202 0.0048 GCCTGGCCAACATGGCAAAACGTCGTGTCTA
  piR-34946 3.446885753 0.0014 TCATGAGGTCAGGAGTTCAAGACCAGCC
  piR-43219 3.389853452 0.0032 CACCTTGGGAGGCCAAGGCAGGCAGATCAT
  piR-38034 3.316586523 0.0068 TCGCTTGAACCTGGAAGGCGGAGGTTGC
  piR-70732 0.359078784 0.057 TGATGATGGTGGTGGTGGTGTCGGTGA
apiRNA expression was compared between alcohol drinkers and non-drinkers in the non-smoking cohort (n=18). bpiRNA expression was compared 
between alcohol drinkers and non-drinkers in all patients (n=40). piRNA, PIWI-interacting RNA; PIWI, P-element-induced wimpy testis.
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piRNA expression due to alcohol consumption. In this study, 
the expression of 23,439 piRNA transcripts in alcohol drinkers 
and non-drinkers were compared. Among the 3,223 piRNA 
transcripts consistently detected among the samples, piR-58510, 
-34946, -43219, -38034 and -70732 (Table II) were significantly 
differentially expressed in alcohol-drinking HNSCC patients 
(fold change of ≥2 in all patients), while piR‑258904, ‑35373, 
-266308 and -34946 (Table II) were significantly differentially 
expressed in the non-smoker cohort. Notably, only piR-34946 
was identified in the analysis of both cohorts, which suggests 
that the synergistic effect between alcohol and tobacco usage 
may affect piRNA expression, and that this piRNA may be 
involved in the effects of both major risk factors. Previous 
studies have revealed an association between alcohol 
Figure 2. Long term ethanol exposure and acetaldehyde treatment leads to dysregulation of identified piRNAs in vitro. Quantitative reverse-transcription 
polymerase chain reaction demonstrated that demonstrate that (A) ethanol and (B) acetaldehyde treatment of normal OKF4 and OKF6 oral epithelial cell 
cultures increases piRNA 35373, -266308, -58510 and -38034 in both cell lines. Data are presented as the mean ± standard deviation. PIWI, P-element-induced 
wimpy testis; piRNA, PIWI-interacting RNA. *P<0.05 vs. control.
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consumption and tobacco exposure an epigenetic dysregula-
tion of ncRNAs (23,24). Furthermore, ncRNA dysregulation 
has been implicated in a number of cancer types (12). To 
date, none of the piRNAs identified in the present study have 
been functionally characterized and thus, their involvement 
in cancer progression remains unclear. The 3,223 piRNA 
transcripts consistently detected among the clinical patient 
samples was significantly less than the increasing number of 
piRNAs that have already been identified. This suggests that 
cancer cells, or specifically HNSCC cells, may not express the 
same number of piRNAs as germ line cells (25,26).
In the present study, RNA-seq data of HNSCC clinical 
samples was used to determine the differential expression 
of all expressed piRNA transcripts and to identify a panel of 
significantly dysregulated piRNAs in the alcohol-drinkers 
when compared with non-drinkers. To identify piRNAs with 
the greatest potential functional significance, the correla-
tion between the expression levels of candidate transcripts 
in HNSCC patients and overall survival was analyzed using 
univariate and multivariate Cox regression analyses. The 
results identified low expression of 2 piRNAs, piR‑58510 and 
piR‑35373, was significantly associated with improved survival. 
Low expression of piR-58510 and piR-35373 correlated with 
longer survival times indi cating that these piRNAs may act as 
oncogenes and thus, may present potential prognostic markers. 
This is the first study to reveal a correlation between piRNA 
expression and improved patient prognosis, which highlights 
the clinical relevance of piRNAs. Furthermore, 4 previously 
uncharacterized piRNAs, piR-35373, piR-266308, piR-58510 
and piR-38034, and a PIWI protein that are hypothesized to 
be involved in the early events of alcohol-associated HNSCC 
pathogenesis were iden tified in non‑cancerous oral keratino-
cytes. Using blat, a BLAST-like alignment tool (http://genome.
ucsc.edu), piR-35373 revealed a sense overlap with the mRNA 
transcript of 3-phosphoglycerate dehydrogenase (PHGDH), a 
serine metabolism-associated protein that is highly expressed 
in several breast cancer subtypes and invasive lobular carci-
noma (27,28). piR-35373 may act as a transcriptional regulator 
of PHGDH expression; however, the underlying molecular 
mechanism remains to be elucidated. PIWIL4 is upregulated 
in human cervical cancer tissues compared with adjacent 
normal tissues and thus acts as an oncogene by promoting 
cell growth and invasion and by downregulating p14ARF and 
p53 (16). The in vitro data obtained in the present study indi-
cates that the alcohol-associated pathogenesis of HNSCC may 
be initiated by the dysregulation of PIWIL4 and its associated 
piRNAs.
Although the exact molecular function of the piRNAs 
identified remains unclear, we hypothesize that these piRNAs 
contribute to carcinogenesis by regulating gene expression 
of certain oncogenes or tumor suppressors, as demonstrated 
in previous piRNA studies (14,16). We acknowledge that 
the relatively limited number of patient datasets available in 
the database and the fact that only in‑vitro validation was 
performed provide possible limitations to this study. Despite 
these limitations, we strongly endorse that these results 
demonstrate that alcohol consumption causes dysregulation of 
piRNA expression in HNSCC samples and in vitro data identi-
fied 4 piRNAs that may potentially serve as therapeutic targets 
or biomarkers for early detection of HNSCC.
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